Cite
HARVARD Citation
Liu, C. et al. (2015). Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction. International journal of cardiology. pp. 22-32. [Online].